We are live on
!
Find out more
NCM
Northroad Capital Management Portfolio holdings
AUM
$43.8M
1-Year Est. Return
1.99%
This Fund
S&P 500
This Quarter
Est. Return
-1.74%
1 Year Est. Return
+1.99%
3 Year Est. Return
+0.16%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$130M
AUM Growth
-$24.4M
(-16%)
Cap. Flow
-$18.8M
Cap. Flow
% of AUM
-14.42%
Top 10 Holdings %
Top 10 Hldgs %
37.06%
Holding
55
New
1
Increased
2
Reduced
50
Closed
2
Avg Time Held
9.6
quarters
Top 10 Avg Time Held
3.9
quarters
Top 20 Avg Time Held
6.2
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$3.49M |
| 2 |
Novartis
NVS
|
+$890K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SYT
Syngenta Ag
SYT
|
+$2.77M |
| 2 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$941K |
| 3 |
Diageo
DEO
|
+$932K |
| 4 |
SAP
SAP
|
+$775K |
| 5 |
WPP
WPP
|
+$724K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.36% |
| 2 | Technology | 14.32% |
| 3 | Healthcare | 12.46% |
| 4 | Financials | 12.33% |
| 5 | Energy | 7.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Diageo
DEO
$50.3B
| $6.18M | 4.75% |
54,770
-8,615
| -14% | -$932K |
2013 Q2
12 quarters
|
|
|
2
Novartis
NVS
$271B
| $5.46M | 4.19% |
73,905
+12,887
| +21% | +$890K |
2013 Q2
12 quarters
|
|
|
RDS.A
3
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $4.97M | 3.82% |
94,987
-19,518
| -17% | -$941K |
2013 Q2
12 quarters
|
|
4
TE Connectivity
TEL
$62.5B
| $4.87M | 3.74% |
85,292
-10,376
| -11% | -$625K |
2014 Q4
6 quarters
|
|
5
Sensata Technologies
ST
$6.19B
| $4.57M | 3.5% |
130,829
-15,837
| -11% | -$579K |
2015 Q4
2 quarters
|
|
|
6
SAP
SAP
$254B
| $4.44M | 3.41% |
59,194
-9,881
| -14% | -$775K |
2013 Q2
12 quarters
|
|
7
TotalEnergies
TTE
$196B
| $4.39M | 3.37% |
91,272
-14,704
| -14% | -$704K |
2013 Q2
12 quarters
|
|
|
8
WPP
WPP
$5.59B
| $4.08M | 3.13% |
39,007
-6,328
| -14% | -$724K |
2013 Q2
12 quarters
|
|
9
GSK
GSK
$92.7B
| $3.61M | 2.77% |
66,570
-10,492
| -14% | -$553K |
2013 Q2
12 quarters
|
|
|
AKZOY
10
DELISTED
Akzo Nobel NV
AKZOY
| $3.6M | 2.77% |
171,334
-26,067
| -13% | -$548K |
2013 Q2
12 quarters
|
|
11
Teva Pharmaceutical Industries Limited
TEVA
$48.1B
| $3.53M | 2.71% |
70,250
-8,936
| -11% | -$476K |
2013 Q2
12 quarters
|
|
12
CRH
CRH
$53.3B
| $3.51M | 2.7% |
118,813
-18,898
| -14% | -$553K |
2013 Q2
12 quarters
|
|
13
Ericsson
ERIC
$31.6B
| $3.33M | 2.55% |
433,227
-66,771
| -13% | -$547K |
2013 Q2
12 quarters
|
|
|
14
Baidu
BIDU
$28.5B
| $3.29M | 2.52% |
+19,891
| New | +$3.49M |
2016 Q2
0 quarters
|
|
15
Perrigo
PRGO
$2.13B
| $3.15M | 2.42% |
34,728
-4,186
| -11% | -$434K |
2015 Q4
2 quarters
|
|
16
Mitsubishi UFJ Financial
MUFG
$252B
| $3.06M | 2.35% |
691,159
-109,411
| -14% | -$517K |
2013 Q2
12 quarters
|
|
|
AXA
17
DELISTED
AXA ADS (1 ORD SHS)
AXA
| $3M | 2.3% |
148,849
-23,425
| -14% | -$471K |
2013 Q2
12 quarters
|
|
18
HSBC
HSBC
$324B
| $2.64M | 2.03% |
94,615
-14,311
| -13% | -$405K |
2013 Q2
12 quarters
|
|
19
DELISTED
HITACHI LTD ADR (10COM)NEW
HIT
| $2.57M | 1.98% |
61,927
-7,670
| -11% | -$319K |
2015 Q3
3 quarters
|
|
|
TKP
20
DELISTED
TECHNIP ADS (EA REPTG ONE ORD SHS)
TKP
| $2.57M | 1.97% |
189,831
-25,054
| -12% | -$339K |
2013 Q4
10 quarters
|
|
21
ING
ING
$95B
| $2.48M | 1.91% |
240,439
-29,673
| -11% | -$352K |
2014 Q3
7 quarters
|
|
22
BHP
BHP
$216B
| $2.44M | 1.87% |
95,580
-14,902
| -13% | -$371K |
2013 Q2
12 quarters
|
|
|
SYT
23
DELISTED
Syngenta Ag
SYT
| $2.38M | 1.83% |
31,009
-34,247
| -52% | -$2.77M |
2013 Q2
12 quarters
|
|
|
CS
24
DELISTED
Credit Suisse Group
CS
| $1.97M | 1.51% |
183,907
-28,581
| -13% | -$390K |
2013 Q2
12 quarters
|
|
25
Barclays
BCS
$76.9B
| $1.39M | 1.06% |
194,650
-23,610
| -11% | -$212K |
2014 Q3
7 quarters
|
|
Similar funds
CC
RAM
ACI
QCM
NHG
RVGI
BS
BSCM
Northroad Capital Management's Q2 2016 Portfolio in Review
As of Q2 2016, Northroad Capital Management held 55 positions worth $130M, down 16% from $155M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Northroad Capital Management withdrew a net $18.8M in Q2 2016, closing 2 positions and reducing 50 holdings. Its most notable exit was Microsoft, an estimated $459K position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 32% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Northroad Capital Management opened a new position in Baidu worth $3.29M.
- Northroad Capital Management's largest Q2 2016 buy was Baidu: 19,891 shares worth $3.29M.
- Northroad Capital Management added most to Novartis in Q2 2016, an estimated $890K increase.
- Northroad Capital Management's biggest Q2 2016 reduction was Syngenta Ag, cutting an estimated $2.77M.
- Northroad Capital Management fully exited Microsoft in Q2 2016, selling an estimated $459K.
- Northroad Capital Management's ten largest holdings make up 37% of its $130M portfolio in Q2 2016.
- Northroad Capital Management opened 1 new position and closed 2 in Q2 2016.
- Northroad Capital Management's portfolio value fell 16% quarter-over-quarter to $130M.
Based on Northroad Capital Management's 13F filing for Q2 2016, filed 17 Aug 2016.